Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging
Heart-Wave
1 other identifier
observational
20
1 country
1
Brief Summary
This study wish to assess the reproducibility of baseline and hyperemic myocardial blood flow as well as myocardial blood flow reserve measurements with \[O15\]H2O-PET-MPI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 17, 2026
CompletedApril 6, 2025
August 1, 2024
11 months
March 13, 2024
April 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
[O15]H2O-PET-MPI variability and repeatability coefficient estimated from 20 patients having [O15]H2O-PET-MPI done twice
In this study two \[O15\]H2O-PET-CT scans in the same induvidual at two different timepoints will be conducted. This will allow a variability estimation (for each meassurement eg rest MBF (ml/g/min), stress MBF (ml/g/min)) and thereby a calculated repeatability coefficient.
8 months
Study Arms (1)
re-pet participant
Participant are enrolled for a second pet-scan which will be compared with the initial scan.
Interventions
Re-scan for comparison with initial scan
Eligibility Criteria
Patients \> 50 years of age with symptoms suggestive of myocardial ischemia, primarily angina. They have therefore undergone \[O15\]H2O-PET-MPI by the dept. of cardiology on clinical indication. The investigators will include 50% women.
You may qualify if:
- Patients \> 50 years of age referred for \[O15\]H2O-PET-MPI by the dept. of cardiology on clinical indication with symptoms suggestive of myocardial ischemia, primarily angina.
- Willing to repeat the \[O15\]H2O-PET-MPI
- Normal left ventricular ejection fraction (EF \> 45), as assessed from recent (max 1 year old) echocardiography description in medical journal.
You may not qualify if:
- Cardiovascular event in between scans (defined as hospitalization for cardiovascular event).
- History of myocardial infarction
- Regional perfusion deficits on the primary \[O15\]H2O-PET-MPI clinically suspected as a sign of significant coronary stenosis.
- Unstable angina
- Severe Chronic Obstructive Pulmonary Disease (COPD)
- Severe asthma
- Claustrophobia
- Acute illness
- Significant language barrier, estimated by the investigator not being able to understand the study information sufficiently.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peter Hovindlead
Study Sites (1)
Bispebjerg Hospital
Copenhagen, RegionH, 2400, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Peter Hovind, MD, Phd.
Bispebjerg hospital, capitol region Denmark
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of department, Department of Clinical Physiology and Nuclear Medicine and PET
Study Record Dates
First Submitted
March 13, 2024
First Posted
April 10, 2024
Study Start
April 15, 2024
Primary Completion
March 17, 2025
Study Completion
March 17, 2026
Last Updated
April 6, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share